Investors in Abbvie can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the American market. Per share the analysts expect a dividend of 3,54 USD per share. Abbvie's dividend yield thus equals 3,87 percent. The average dividend yield of the biotech companies equals a limited 1 percent.
Tomorrow Abbvie will publish its past quarter's results. For this year Abbvie's revenue will be around 32,24 billion USD. This is according to the average of the analysts' estimates. This is rather significant more than 2016's revenue of 28,22 billion USD.
The analysts expect for 2018 a net profit of 11,97 billion USD. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 7,55 USD. With this the price/earnings-ratio is 12,1.
Based on the current number of outstanding shares Abbvie's market capitalization is 145,49 billion USD. On Monday the stock closed at 91,36 USD.ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.